標(biāo)題: Titlebook: Management of Neuroendocrine Tumors of the Pancreas and Digestive Tract; From Surgery to Targ Eric Raymond,Sandrine Faivre,Philippe Rusznie [打印本頁] 作者: 召集會議 時間: 2025-3-21 16:41
書目名稱Management of Neuroendocrine Tumors of the Pancreas and Digestive Tract影響因子(影響力)
書目名稱Management of Neuroendocrine Tumors of the Pancreas and Digestive Tract影響因子(影響力)學(xué)科排名
書目名稱Management of Neuroendocrine Tumors of the Pancreas and Digestive Tract網(wǎng)絡(luò)公開度
書目名稱Management of Neuroendocrine Tumors of the Pancreas and Digestive Tract網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Management of Neuroendocrine Tumors of the Pancreas and Digestive Tract被引頻次
書目名稱Management of Neuroendocrine Tumors of the Pancreas and Digestive Tract被引頻次學(xué)科排名
書目名稱Management of Neuroendocrine Tumors of the Pancreas and Digestive Tract年度引用
書目名稱Management of Neuroendocrine Tumors of the Pancreas and Digestive Tract年度引用學(xué)科排名
書目名稱Management of Neuroendocrine Tumors of the Pancreas and Digestive Tract讀者反饋
書目名稱Management of Neuroendocrine Tumors of the Pancreas and Digestive Tract讀者反饋學(xué)科排名
作者: 草本植物 時間: 2025-3-21 23:35 作者: NEX 時間: 2025-3-22 03:30
Advances with Somatostatin Analogs in Neuroendocrine Tumors; The Promise of Radionuclides in Neuroend dual-targeting chimeric molecules. Conjugation of SST analogs with radionuclides has also been used for peptide-receptor-targeted radiotherapy (PRRT) in advanced NETs, with promising results. This chapter summarizes key preclinical and clinical data on the antisecretory and antitumor effects of S作者: ALE 時間: 2025-3-22 05:54
Streptozocin-Based Chemotherapy: Still a Standard of Care for Neuroendocrine Tumours?, therapies and this may be important in those who are symptomatic from tumour burden and those with locally advanced disease who may be down-staged for resection. The role of Ki67 and other predictive markers requires further assessment in prospective studies as does the relative efficacy of alterna作者: 試驗 時間: 2025-3-22 12:23 作者: GUISE 時間: 2025-3-22 13:46
Angiogenesis Inhibition Using Sunitinib in Pancreatic Neuroendocrine Tumors, trial. In this later study, sunitinib demonstrated significant benefits in terms of progression-free survival and response rate in patients with advanced well-differentiated pancreatic neuroendocrine tumors. The safety profile in this patient population was consistent with previously reported data 作者: auxiliary 時間: 2025-3-22 19:49
Clinical Management of Targeted Therapies in Neuroendocrine Tumours,ons, and providing strategies to overcome them is a further important component of patient care. At the core of clinical management is effective communication between patients and physicians, which ensures patients are fully involved in decisions concerning their care, and will allow advances in the作者: 擁護者 時間: 2025-3-22 22:38
Imaging of Neuroendocrine Tumors and Challenges in Response Evaluation for Targeted Therapies,ving targeted agents. In this chapter, we aimed to review the various imaging techniques used to characterize neuroendocrine tumors in routine clinic and clinical trials. We also challenge the potential advantages of those imaging techniques for the evaluation of response in patients with neuroendoc作者: 中世紀(jì) 時間: 2025-3-23 02:01
Overcoming Resistance to Targeted Therapies: The Next Challenge in Pancreatic Neuroendocrine Tumorsesponse) resistance to antiangiogenic agents and mTOR inhibitors, using data available from preclinical and clinical studies in various malignancies. Herein, we also describe how these general mechanisms of resistance may emerge in patients with PNET treated with sunitinib and everolimus. Overcoming作者: ECG769 時間: 2025-3-23 08:01 作者: ETCH 時間: 2025-3-23 11:15 作者: employor 時間: 2025-3-23 15:11 作者: 疲勞 時間: 2025-3-23 18:38
Saira Khalique,Tim Meyerr zahlreichen Regeln und Tipps. Kompetent und kurzweilig geschrieben - ein echtes Lesevergnügen..Rosemarie Wrede-Grischkat schult seit zwanzig Jahren als freiberufliche Dozentin für Umgangsformen Führungskr?fte der Wirtschaft und offiz978-3-8349-9234-5作者: 半導(dǎo)體 時間: 2025-3-23 22:11
Aaron I. Vinik,Etta Vinik,Anne Diebold,Eugene Wolteringtion of dark matter involve processes (such as collisions with, absorption by or inter-conversion with ordinary matter) that are either quartic (g4) or quadratic (g2) in an underlying interaction constant g..978-3-319-87550-7978-3-319-63417-3Series ISSN 2190-5053 Series E-ISSN 2190-5061 作者: 浪費時間 時間: 2025-3-24 03:59
es, targeted therapies such as tyrosine kinase and mTOR inhibitors, antiangiogenic compounds, but also peptide-receptor targeted therapy or radioembolization. This changing field has generated novel treatment a978-2-8178-0554-2978-2-8178-0430-9作者: Congregate 時間: 2025-3-24 10:22
S. Cingarlini,M. Bonomi,C. Trentin,V. Corbo,A. Scarpa,G. Tortora作者: cluster 時間: 2025-3-24 13:39 作者: PRISE 時間: 2025-3-24 16:14 作者: 思想 時間: 2025-3-24 22:02 作者: 大看臺 時間: 2025-3-24 23:41
el entdeckt hatte, verwandte, um zu beweisen, da? Augustins Lehre von der Erbsünde nichts anderes sei als die Annahme eines Gott entgegengesetzten Prinzips des B?sen, d h manich?isch. Von dieser Schrift . sind uns die ersten sechs Bücher überliefert, da Augustinus sie in seiner Gegenschrift .. absch作者: idiopathic 時間: 2025-3-25 05:12 作者: parsimony 時間: 2025-3-25 10:33
Jacques Belghiti,Sébastien Gaujoux,Marleny Figueiredo,David Fuks,Alain Sauvanetas fortuites, soit parce qu’il existe des arguments épidémiologiques indiscutables, soit parce qu’un lien de causalité a pu être démontré. Nous utiliserons le terme de paraprotéine pour désigner la présence anormale d’une immunoglobuline monoclonale ou d’un produit dérivé d’une immunoglobuline (cha?作者: 痛恨 時間: 2025-3-25 13:25 作者: 慢跑鞋 時間: 2025-3-25 16:35
Eric Raymond,Marianne Pavelle alors de colites inclassées. Le bilan diagnostique minimum à réaliser en cas de suspicion deMICI est le suivant: hémogramme, VS, CRP (une augmentation doit attirer l’attention), anticorps anti-. (ASCA), anticorps anti-cytoplasme des neutrophiles (ANCA), fibroscopie oeso-gastro-duodénale et iléoco作者: cinder 時間: 2025-3-25 23:50 作者: 不近人情 時間: 2025-3-26 00:44
L. Carter,R. A. Hubner,J. W. Vallele alors de colites inclassées. Le bilan diagnostique minimum à réaliser en cas de suspicion deMICI est le suivant: hémogramme, VS, CRP (une augmentation doit attirer l’attention), anticorps anti-. (ASCA), anticorps anti-cytoplasme des neutrophiles (ANCA), fibroscopie oeso-gastro-duodénale et iléoco作者: 懲罰 時間: 2025-3-26 06:52
Maxime Ronot,Chantal Dreyer,Olivia Hentic,Magaly Zappa,Cristian Mateescu,Anne Couvelard,Pascal Hammele alors de colites inclassées. Le bilan diagnostique minimum à réaliser en cas de suspicion deMICI est le suivant: hémogramme, VS, CRP (une augmentation doit attirer l’attention), anticorps anti-. (ASCA), anticorps anti-cytoplasme des neutrophiles (ANCA), fibroscopie oeso-gastro-duodénale et iléoco作者: AUGUR 時間: 2025-3-26 10:54
Annemila? Tijeras-Raballand,Cindy Neuzillet,Anne Couvelard,Maria Serova,Armand de Gramont,Pascal Hamdécrites ces dernières années.. Deux facteurs ont vraisemblablement contribué à l’émergence de ces rickettsioses : l’augmentation des interactions hommes-tiques (voyages, séjours en forêt) et le développement desméthodes de diagnostic et d’identification des agents infectieux, en particulier l’utili作者: forthy 時間: 2025-3-26 13:43 作者: Accrue 時間: 2025-3-26 20:27 作者: 慢慢流出 時間: 2025-3-26 23:26
kirchlichen Lehre, da? der Mensch von Geburt an durch die Erbsünde schuldbeladen sei und zur Erl?sung der Gnade Gottes bedürfe, dazu aus eigener Kraft nicht in der Lage sei, vertraten gegen Ende des 4. und zu Beginn des 5. Jh. die Pelagianer, deren Hauptvertreter Pelagius, Caelestius und Iulianus vo作者: obtuse 時間: 2025-3-27 04:44 作者: Truculent 時間: 2025-3-27 05:29 作者: 陳舊 時間: 2025-3-27 10:07 作者: 別炫耀 時間: 2025-3-27 16:39
Jacques Belghiti,Sébastien Gaujoux,Marleny Figueiredo,David Fuks,Alain Sauvanetnification indéterminée ? (anciennement ? dysglobulinémie monoclonale bénigne ?) dans plus de 60% des cas. Ailleurs, elle peut révéler un myélome, une maladie de Waldenstr?m, un lymphome, une leucémie lympho?de chronique, une amylose ou un plasmocytome.. Il est établi que 15% environ des sujets avec作者: Incorporate 時間: 2025-3-27 20:42 作者: epidermis 時間: 2025-3-28 01:12 作者: Mobile 時間: 2025-3-28 05:12 作者: 遣返回國 時間: 2025-3-28 07:04 作者: 呼吸 時間: 2025-3-28 11:04 作者: Palliation 時間: 2025-3-28 16:14 作者: 寬敞 時間: 2025-3-28 19:35 作者: Coordinate 時間: 2025-3-29 01:47 作者: Hormones 時間: 2025-3-29 06:04
Geertrui Mertens,Saskia Carton,Chris Verslype,Eric Van Cutsem. On the one hand, the static analysis of intentional acts and intentional objects is proposed as the appropriate means by which to understand perceptual sense. On the other hand, Husserl’s genetic phenomenology has been offered as a new approach by which to understand the role of perceptual sense i作者: INCUR 時間: 2025-3-29 10:56
Scintigraphy in Endocrine Tumors of the Gut,umors (NETs). Most NETs overexpress the somatostatin receptor mainly sst2. Somatostatin receptor scintigraphy with .In-DTPA-0octreotide has proven its role in the diagnosis and staging of gastroenteropancreatic NETs. The use of .Ga-labeled analogs of octreotide for PET imaging, with of different rad作者: 持久 時間: 2025-3-29 14:14 作者: Sedative 時間: 2025-3-29 19:14 作者: 昏迷狀態(tài) 時間: 2025-3-29 21:40
Advances with Somatostatin Analogs in Neuroendocrine Tumors; The Promise of Radionuclides in Neuroeacterized by high SST receptor expression levels, mainly of subtype 2 (SSTR2), which is the basis for SST use in imaging and therapeutic strategies in digestive NETs. Since the 1980s, SST analogs (octreotide and lanreotide) have been widely prescribed to relieve symptoms resulting from hormonal hype作者: 畫布 時間: 2025-3-30 03:05 作者: Pillory 時間: 2025-3-30 04:19
Place of Surgical Resection in the Treatment Strategy for Gastrointestinal Neuroendocrine Tumors,ts have metastatic or locally advanced tumors, surgery, from resection to transplantation, remains the only potential curative option for these patients and should always be considered. Nevertheless, because of the very few randomized controlled trials available, the optimal place of surgery within 作者: 雜役 時間: 2025-3-30 12:08 作者: Cognizance 時間: 2025-3-30 15:11 作者: B-cell 時間: 2025-3-30 19:39
Angiogenesis Inhibition Using Sunitinib in Pancreatic Neuroendocrine Tumors,r (VEGFR) activation for endothelial proliferation and on platelet-derived growth factor receptor (PDGFR) function for pericyte coverage. Expression of VEGF by cancer cells is thought to be induced by hypoxia-inducing factor 1 alpha that can be caused either by hypoxia or by genetic abnormalities su作者: 的闡明 時間: 2025-3-30 23:14
Clinical Management of Targeted Therapies in Neuroendocrine Tumours,). Clinical management of patients receiving targeted therapies aims to maximise the benefits patients achieve whilst minimising the impact of side effects to maintain quality of life. Adverse event management requires physicians to control co-morbidities, carefully review medication histories and t作者: HIKE 時間: 2025-3-31 03:58 作者: 臭了生氣 時間: 2025-3-31 05:48
Overcoming Resistance to Targeted Therapies: The Next Challenge in Pancreatic Neuroendocrine TumorsRecently, data from two large placebo controlled phase III trials have changed the therapeutic landscape. They demonstrated that targeted therapies directed against receptor of vascular endothelial growth factor (VEGFR) (sunitinib) and mammalian target of rapamycin (mTOR) (everolimus) produced clini作者: Feckless 時間: 2025-3-31 10:11 作者: FACT 時間: 2025-3-31 15:11
Measuring the Relationship of Quality of Life and Health Status: Including Tumor Burden, Symptoms, as well as the social, emotional, psychological, and physical functioning of these patients. In this chapter, we describe two tools that have been developed to assess the wide spectrum of NET symptoms, determine the impact of this disease on patient’s overall well-being, and discriminate between pat
